Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Enteric Coating of Mycophenolate Reduces Dosage Adjustments
Transplantation Proceedings, 07/02/09
Brister K et al. - Mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS) are bioequivalent. However, the effectiveness of MMF may be limited by gastrointestinal (GI) side effects. Patients receiving MMF required more immunosuppressive medication adjustments, which may complicate care and decrease overall compliance.
Related Articles
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Relevance Score: 85%
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
Liver Transplantation, 11/03/09
Relevance Score: 84%
Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: Successful treatment with mycophenolate mofetil and corticosteroids
Respiratory Medicine, 10/14/09
Relevance Score: 84%
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Relevance Score: 83%
Safety and Tolerance of Sodium Mycophenolate in Patients After Renal Transplantation--An Observational Study
Transplantation Proceedings, 11/05/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ketorolac is Underutilized After Ureteral Reimplantation Despite Reduced Hospital Cost and Reduced Length of Stay
Urology, 02/09/10
The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders : A Pilot Study
Urology, 02/09/10
Intraoperative administration of dexmedetomidine reduces the analgesic requirements for children undergoing hypospadius surgery
European Journal of Anaesthesiology, 02/09/10
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients
American Journal of Transplantation, 02/09/10
Randomized Controlled Trial: Lisinopril Reduces Proteinuria, Ammonia, and Renal Polypeptide Tubular Catabolism in Patients With Chronic Allograft Nephropathy
Transplantation, 02/09/10
Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial
American Journal of Transplantation, 02/09/10
Article Search
Sponsor


See Latest Articles


